Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cancer Exosomes and Natural Killer Cells Dysfunction: Biological Roles, Clinical Significance and Implications for Immunotherapy Publisher Pubmed



Hosseini R1 ; Sarvnaz H2 ; Arabpour M3 ; Ramshe SM4 ; Asefkabiri L5 ; Yousefi H6 ; Akbari ME5 ; Eskandari N1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Immunology School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Medical Genetics School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Student Research Committee, Department of Medical Genetics, School of Medicine Shahid, Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Surgical Oncologist Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, United States

Source: Molecular Cancer Published:2022


Abstract

Tumor-derived exosomes (TDEs) play pivotal roles in several aspects of cancer biology. It is now evident that TDEs also favor tumor growth by negatively affecting anti-tumor immunity. As important sentinels of immune surveillance system, natural killer (NK) cells can recognize malignant cells very early and counteract the tumor development and metastasis without a need for additional activation. Based on this rationale, adoptive transfer of ex vivo expanded NK cells/NK cell lines, such as NK-92 cells, has attracted great attention and is widely studied as a promising immunotherapy for cancer treatment. However, by exploiting various strategies, including secretion of exosomes, cancer cells are able to subvert NK cell responses. This paper reviews the roles of TDEs in cancer-induced NK cells impairments with mechanistic insights. The clinical significance and potential approaches to nullify the effects of TDEs on NK cells in cancer immunotherapy are also discussed. © 2022, The Author(s).
Other Related Docs
9. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
12. Tumor Immunology, Clinical Immunology (2022)
14. Exosomes and Cancer, Synthesis Lectures on Biomedical Engineering (2022)
15. Advances in Natural Killer Cell Therapies for Breast Cancer, Immunology and Cell Biology (2023)
19. Car-Nk Cell: A New Paradigm in Tumor Immunotherapy, Frontiers in Oncology (2021)
24. Role of Exosome in Autoimmunity, With a Particular Emphasis on Rheumatoid Arthritis, International Journal of Rheumatic Diseases (2021)
27. Car-Nk Cells: A Promising Cellular Immunotherapy in Lymphoma, Expert Opinion on Biological Therapy (2023)
29. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
39. Non-Coding Rnas in Cancer Immunotherapy: A Solution to Overcome Immune Resistance?, Progress in Molecular Biology and Translational Science (2024)
45. Whole Tumor Cell Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
47. General Concepts of Immunity, Encyclopedia of Infection and Immunity (2022)